Light it up: highly efficient multigene delivery in mammalian cells.

Bioessays

European Molecular Biology Laboratory-EMBL, Grenoble, France.

Published: December 2011

Multigene delivery and expression systems are emerging as key technologies for many applications in contemporary biology. We have developed new methods for multigene delivery and expression in eukaryotic hosts for a variety of applications, including production of protein complexes for structural biology and drug development, provision of multicomponent protein biologics, and cell-based assays. We implemented tandem recombineering to facilitate rapid generation of multicomponent gene expression constructs for efficient transformation of mammalian cells, resulting in homogenous cell populations. Analysis of multiple parameters in living cells may require co-expression of fluorescently tagged sensors simultaneously in a single cell, at defined and ideally controlled ratios. Our method enables such applications by overcoming currently limiting challenges. Here, we review recent multigene delivery and expression strategies and their exploitation in mammalian cells. We discuss applications in drug discovery assays, interaction studies, and biologics production, which may benefit in the future from our novel approach.

Download full-text PDF

Source
http://dx.doi.org/10.1002/bies.201100109DOI Listing

Publication Analysis

Top Keywords

multigene delivery
16
mammalian cells
12
delivery expression
12
light highly
4
highly efficient
4
multigene
4
efficient multigene
4
delivery
4
delivery mammalian
4
cells
4

Similar Publications

sp. KMM 8419 (=CB1-14) is a Gram-negative bacterium isolated from a food-net mucus sample of marine polychaete collected in the Sea of Japan. Here, we report the structure and biosynthetic gene cluster of the capsular polysaccharide (CPS) from strain KMM 8419.

View Article and Find Full Text PDF
Article Synopsis
  • * The study found that using alternative viral promoters, specifically Orf-13 and Orf-81, significantly reduced VSV-G expression, improving the stability and morphology of BVs.
  • * With optimized VSV-G levels, BVs maintained efficient gene delivery and CRISPR editing capabilities, demonstrating that less VSV-G expression can actually enhance the overall effectiveness and stability of the vectors. *
View Article and Find Full Text PDF
Article Synopsis
  • Multi-gene hereditary cancer screenings can enhance prevention and treatment for patients and their families, but require integration into various cancer care settings to ensure diverse communities benefit.
  • A survey of 230 diverse cancer patients revealed a strong intent to share genetic results with family, but this intent varied; patients were more likely to disclose to sisters than brothers, and many were uncertain about sharing with at-risk relatives.
  • Recognizing the factors influencing sharing decisions among patients can help clinicians improve genetic screening support and address disparities in cancer care.
View Article and Find Full Text PDF

Background: This study evaluated a new mainstream genetic testing pathway for hereditary cancer, with expanded eligibility for early-stage breast cancer patients.

Methods: The study compared multigene panel (62 genes) germline testing uptake and results for breast cancer patients at 4 pilot sites (n = 502 patients) and 10 non-pilot sites (n = 1792 patients) within Kaiser Permanente Northern California from December 2020, to June 2021. At the pilot sites, breast care coordinators (BCCs) offered and consented patients for testing, with eligibility expanded to include all patients age 65 years or younger.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!